Bayer and Regeneron Extend Development Program for VEGF Trap-Eye … – PR Newswire (press release)

table border=0 width= valign=top cellpadding=2 cellspacing=7trtd valign=top class=jfont style=font-size:85%;font-family:arial,sans-serifbrdiv style=padding-top:0.8em;img alt= height=1 width=1/divdiv class=lha href=http://news.google.com/news/url?sa=Tct=us/9-0fd=Rurl=http://sev.prnewswire.com/health-care-hospitals/20090430/NY0828930042009-1.htmlcid=1343708150ei=4ib6SZT5BovGsgbc27S1Agusg=AFQjCNEJTL_8Rt2U_nhQ1ZFv-YPZ1olYDQBayer and Regeneron Extend Development bProgram/b for VEGF Trap-Eye b…/b/abrfont size=-1font color=#6f6f6fPR Newswire (press release),nbsp;NY/font/fontbrfont size=-1Bayer HealthCare Pharmaceuticals Inc. is the US-based pharmaceuticals operation of Bayer HealthCare, an baffiliate/b of Bayer AG. One of the world#39;s leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines b…/b/font/div/font/td/tr/table

More: continued here